IllExcor Therapeutics is committed to the discovery and development of new therapeutics to treat a range of blood-related diseases and conditions, including Sickle Cell Disease, hypoxia, and ischemia.
9/22/2020U.S. Department of Commerce Commits Nearly $1 Million to Expand RAMP
9/18/2020Vibrent Health Wins NIH Contract to Develop Powerful New Digital Health Solutions for COVID-19
9/24/2020Essentials of SBIR Commercialization for Phase I and Phase II -- WEBINAR
9/24/2020Webinar; Fundamentals of Disinfectant Efficacy Testing